FDA Inspection 553070 — Seaside Osteo
The FDA completed an inspection of Seaside Osteo on Dec 22, 2008 in Ellicott City, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 22, 2008
- Fiscal Year
- 2009
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Ellicott City, MD (United States)